STEINMAN LAWRENCE — SEC Form 4 filings
SEC reporting owner CIK 1132679. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-01 to 2026-05-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 133,333 shares, $100,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 133,333 shares @ $0.75 ($100,000) in Pasithea Therapeutics Corp., filed 2025-12-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | Director | 5 | 1 leg · 133,333 sh · $100,000 | — | 4 |
| 180 Life Sciences Corp. (ATNF) | Director | 4 | — | — | 5 |
| BioAtla, Inc. (BCAB) | Director | 2 | — | — | 2 |
Form 4 filings — STEINMAN LAWRENCE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-05 | 4 | Pasithea Therapeutics Corp. (KTTA) | Grant/award (A): 152,783 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Pasithea Therapeutics Corp. (KTTA) | Purchase (P): 133,333 @ $0.75 | EDGAR |
| 2025-10-27 | 4 | Pasithea Therapeutics Corp. (KTTA) | Grant/award (A): 242,913 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | 180 Life Sciences Corp. (ATNF) | Holdings only — no transactions reported | EDGAR |
| 2025-06-30 | 4/A | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 44,959 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 48,198 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | BioAtla, Inc. (BCAB) | Grant/award (A): 23,500 @ $0 | EDGAR |
| 2025-02-21 | 4 | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2024-06-14 | 4 | BioAtla, Inc. (BCAB) | Grant/award (A): 16,500 @ $0 | EDGAR |
| 2024-04-05 | 4/A | Pasithea Therapeutics Corp. (KTTA) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Pasithea Therapeutics Corp. (KTTA) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1132679 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →